CNY 16.14
(0.25%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 13.97 Million | 94.7 Million | 101.23 Million | 27.83 Million | 185.58 Million | 97.51 Million |
Net Income | 21.05 Million | 100.42 Million | 142.37 Million | 109.93 Million | 139.1 Million | 145.99 Million |
Depreciation & Amortization | 15.23 Million | 14.83 Million | 14.42 Million | 381.02 Thousand | 181.96 Thousand | 232.86 Thousand |
Deferred income taxes | -16.1 Million | 469.17 Thousand | 208.54 Thousand | -497.26 Thousand | -448.3 Thousand | -208.4 Thousand |
Stock-based compensation | - | - | - | - | 2.72 Million | - |
Change in working capital | -122.44 Million | -14.63 Million | -52.19 Million | -91.19 Million | 35.03 Million | -68.26 Million |
Other non-cash items | -15.43 Million | -5.91 Million | -3.36 Million | 8.7 Million | 11.26 Million | 19.54 Million |
Investing Cash Flow | -71.67 Million | -783.83 Million | -34.56 Million | -117.11 Million | -41.49 Million | 26.03 Million |
Investments in PPE | -79.68 Million | -105.81 Million | -4.15 Million | -15.75 Million | -3.16 Million | -5.32 Million |
Acquisitions | 53.56 Thousand | 0.42 | 144.48 Thousand | 15.75 Million | 3.18 Million | 5.53 Million |
Investment purchases | -1.13 Billion | -1.3 Billion | -379 Million | -199.8 Million | -326 Million | -114.11 Million |
Sales/Maturities of investments | 1.13 Billion | 625.38 Million | 348.44 Million | 98.44 Million | 287.65 Million | 145.25 Million |
Other Investing Activities | 8 Million | -678.01 Million | 1.36 | -15.75 Million | -3.16 Million | -5.32 Million |
Financing Cash Flow | -44.9 Million | -45.84 Million | 1.43 Billion | -16.53 Million | -69.67 Million | -89.66 Million |
Debt repayment | -309.49 Thousand | -309.49 Thousand | -47 Million | - | -7.25 Million | -2 Million |
Dividends payments | -32.19 Million | -32.19 Million | -1.25 Million | -12.62 Million | -84.02 Million | -95.24 Million |
Common Stock Repurchased | -8.24 Million | - | -39.91 Million | - | - | - |
Common Stock Issuance | - | -11.5 Million | -7.08 Million | -3.91 Million | - | - |
Other Financing Activities | -10.82 Million | -309.49 Thousand | 1.53 Billion | -12.62 Million | 21.6 Million | 7.57 Million |
Accounts receivables | -96.78 Million | 118.96 Million | -59.33 Million | -70.71 Million | 32.01 Million | -88.96 Million |
Accounts payables | 36.92 Million | -160.94 Million | 37.81 Million | 625.65 Thousand | 3.61 Million | 34.44 Million |
Inventory | -46.47 Million | 26.88 Million | -30.87 Million | -20.61 Million | -147.2 Thousand | -13.54 Million |
Other working capital | -262.27 Thousand | 469.17 Thousand | 208.54 Thousand | -497.26 Thousand | -448.39 Thousand | -54.72 Million |
Cash at beginning of period | 783.32 Million | 1.51 Billion | 11.88 Million | 117.71 Million | 43.3 Million | 9.42 Million |
Cash at end of period | 680.72 Million | 783.32 Million | 1.51 Billion | 11.88 Million | 117.71 Million | 43.3 Million |
Capital Expenditure | -79.68 Million | -105.81 Million | -4.15 Million | -15.75 Million | -3.16 Million | -5.32 Million |
Effect of forex changes on cash | - | - | - | 0.63 | - | 1.09 |
Net cash flow / Change in cash | -102.6 Million | -734.97 Million | 1.5 Billion | -105.82 Million | 74.4 Million | 33.88 Million |
Free Cash Flow | -65.7 Million | -11.1 Million | 97.08 Million | 12.07 Million | 182.41 Million | 92.19 Million |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 13.13 Million | 35.56 Million | 18.58 Million | 21.05 Million | 13.17 Million | -64.18 Million |
Depreciation & Amortization | - | 3.56 Million | 3.56 Million | 15.23 Million | 15.54 Million | -8 Million |
Deferred income taxes | - | - | - | -16.1 Million | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | -9.11 Million | - | -122.44 Million | -143.52 Million | 82.7 Million |
Other non-cash items | -18.33 Million | -74.43 Million | -70.83 Million | -15.43 Million | 76.54 Million | -9.28 Million |
Investing Cash Flow | -73.02 Million | -26.84 Million | -42.76 Million | -71.67 Million | 13.77 Million | 58.64 Million |
Investments in PPE | -3.18 Million | -2.2 Million | -6.87 Million | -79.68 Million | 1.68 Million | -4.61 Million |
Acquisitions | 10 Thousand | 11.78 Thousand | - | 53.56 Thousand | 50.73 Thousand | 2829.00 |
Investment purchases | -113 Million | -548.65 Million | -52 Million | -1.13 Billion | -113 Million | -129 Million |
Sales/Maturities of investments | 43.15 Million | 524 Million | 16.11 Million | 1.13 Billion | 125.03 Million | 192.26 Million |
Other Investing Activities | - | -24.04 Million | -35.88 Million | 8 Million | 12.08 Million | 0.54 |
Financing Cash Flow | -45.73 Million | -70.11 Million | -18.12 Million | -44.9 Million | -28.66 Million | -19.65 Million |
Debt repayment | -800 Thousand | -45.2 Million | -50 Million | -309.49 Thousand | -16 Million | -16 Million |
Dividends payments | - | -523.09 Thousand | -746.29 Thousand | -32.19 Million | -32.19 Million | -19.65 Million |
Common Stock Repurchased | - | -91.77 Million | - | -8.24 Million | -8.24 Million | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -44.93 Million | -24.91 Million | -67.38 Million | -10.82 Million | -18.57 Million | -19.65 Million |
Accounts receivables | - | -12.78 Million | - | -96.78 Million | -96.78 Million | 58.97 Million |
Accounts payables | - | - | - | 36.92 Million | - | - |
Inventory | - | 3.21 Million | - | -46.47 Million | -46.47 Million | 22.98 Million |
Other working capital | - | 466.36 Thousand | - | -262.27 Thousand | -262.27 Thousand | 736.22 Thousand |
Cash at beginning of period | 1.06 Billion | 1.2 Billion | 680.72 Million | 783.32 Million | 733.86 Million | 698.51 Million |
Cash at end of period | 1.04 Billion | 1.06 Billion | 567.57 Million | 680.72 Million | 680.72 Million | 733.86 Million |
Capital Expenditure | -3.18 Million | -2.2 Million | -6.87 Million | -79.68 Million | 1.68 Million | -4.61 Million |
Effect of forex changes on cash | - | - | - | - | - | -4.86 Million |
Net cash flow / Change in cash | -19.48 Million | -136.51 Million | -113.14 Million | -102.6 Million | -53.14 Million | 35.35 Million |
Free Cash Flow | -8.38 Million | -44.64 Million | -59.13 Million | -65.7 Million | -36.56 Million | -3.39 Million |
SGRO
300684
SJ
KOHINOOR
KLINIQ
300031